Volume 42, Issue 4, Pages (April 2005)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Volume 46, Issue 6, Pages (December 2004)
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer  Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.
Genome-Wide Analysis of DNA Methylation and the Gene Expression Change in Lung Cancer  Yong-Jae Kwon, PhD, Seog Joo Lee, MSc, Jae Soo Koh, MD, PhD, Sung.
Inflammasomes in liver diseases
Epigenetic Regulation of Cancer Stem Cell Genes in Triple-Negative Breast Cancer  Naofumi Kagara, Kelly T. Huynh, Christine Kuo, Hideyuki Okano, Myung.
KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal Carcinoma  Francesca Zammarchi, Mariangela Morelli, Michele Menicagli, Claudio Di.
KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma  Christina Dahl, Cecilie Abildgaard, Rikke Riber-Hansen, Torben Steiniche, Johanne.
Promoter Methylation and Differential Expression of π-Class Glutathione S-Transferase in Endometrial Carcinoma  Queeny K.Y. Chan, Ui-Soon Khoo, Kelvin.
Volume 135, Issue 1, Pages e3 (July 2008)
Genome-Wide Analysis of DNA Methylation and the Gene Expression Change in Lung Cancer  Yong-Jae Kwon, PhD, Seog Joo Lee, MSc, Jae Soo Koh, MD, PhD, Sung.
Volume 131, Issue 3, Pages (September 2006)
Volume 143, Issue 3, Pages e12 (September 2012)
WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor by Jianming Ying, Hongyu Li, Yun-Wen.
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer  Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.
Volume 116, Issue 2, Pages (February 1999)
Epigenetic Inhibition of Nuclear Receptor Small Heterodimer Partner Is Associated With and Regulates Hepatocellular Carcinoma Growth  Nan He, Kyungtae.
Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer Diagnosis  Seungjae Lee, Sumit Borah, Armita.
Volume 9, Issue 6, Pages (June 2006)
EPS15R, TASP1, and PRPF3 Are Novel Disease Candidate Genes Targeted by HNF4α Splice Variants in Hepatocellular Carcinomas  Monika Niehof, Jürgen Borlak 
Volume 129, Issue 1, Pages (July 2005)
Volume 42, Issue 5, Pages (May 2005)
Volume 47, Issue 2, Pages (July 2012)
Volume 135, Issue 1, Pages e3 (July 2008)
Volume 44, Issue 1, Pages (January 2006)
Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C
Volume 42, Issue 2, Pages (February 2005)
Volume 131, Issue 5, Pages (November 2006)
Volume 133, Issue 6, Pages (December 2007)
Inhibition of DNA Methylation in the COL1A2 Promoter by Anacardic Acid Prevents UV- Induced Decrease of Type I Procollagen Expression  Min-Kyoung Kim,
Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues 
Volume 53, Issue 3, Pages (September 2010)
Volume 139, Issue 2, Pages e4 (August 2010)
S. Sesselmann, M. D. , S. Söder, M. D. , R. Voigt, J. Haag, Ph. D. , S
Volume 124, Issue 3, Pages (March 2003)
RASSF10 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin but Uncommon in Nevus Cell Nevi  Peter Helmbold, Antje M. Richter, Sara.
Volume 11, Issue 2, Pages (February 2007)
Chromatin regulation upon recruitment of HOTAIR
Functional Modulation of Gene Expression by Ultraconserved Long Non-coding RNA TUC338 during Growth of Human Hepatocellular Carcinoma  Hui-Ju Wen, Michael.
KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma  Christina Dahl, Cecilie Abildgaard, Rikke Riber-Hansen, Torben Steiniche, Johanne.
Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage  R.F. Loeser, M.D., H.-J. Im, Ph.D., B. Richardson,
Volume 123, Issue 1, Pages (July 2002)
Hypermethylation of estrogen receptor-α gene in atheromatosis patients and its correlation with homocysteine  Yu-Shan Huang, Yan-Fang Zhi, Shu-Ren Wang 
Volume 132, Issue 4, Pages (April 2007)
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer  Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.
Volume 12, Issue 5, Pages (November 2007)
A LIN28B Tumor-Specific Transcript in Cancer
Imprinted Chromatin around DIRAS3 Regulates Alternative Splicing of GNG12-AS1, a Long Noncoding RNA  Malwina Niemczyk, Yoko Ito, Joanna Huddleston, Anna.
Olivier Humbert, Nancy Maizels  Molecular Therapy - Nucleic Acids 
Remco van Doorn, Willem H. Zoutman, Nelleke A. Gruis 
HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells  Mei Chung.
Epigenetic Control of the S100A6 (Calcyclin) Gene Expression
The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. The human GPR109A promoter is methylated and.
Volume 41, Issue 6, Pages (December 2004)
Epigenetic modifications as new targets for liver disease therapies
Volume 131, Issue 6, Pages (December 2006)
Kei Wada, Chihaya Maesawa, Toshihide Akasaka, Tomoyuki Masuda 
Volume 41, Issue 5, Pages (November 2004)
Functional Modulation of IGF-Binding Protein-3 Expression in Melanoma
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Volume 78, Issue 6, Pages (September 2010)
Molecular Therapy - Nucleic Acids
Volume 25, Issue 11, Pages e6 (December 2018)
Genetics of hepatocellular carcinoma: The next generation
Methylation status of IGFBPL1 in human breast cancer.
Epigenetic regulation of p16INK4a in human gastric cancer.
A, high-resolution methylation analysis of ZNF545 promoter by BGS in representative carcinoma cell lines. A, high-resolution methylation analysis of ZNF545.
The ACIN1 Gene is Hypermethylated in Early Stage Lung Adenocarcinoma
DNA demethylation reactivates GSN expression in gastric cancer cells.
Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C
Presentation transcript:

Volume 42, Issue 4, Pages 511-519 (April 2005) Hypermethylation of NAD(P)H: quinone oxidoreductase 1 (NQO1) gene in human hepatocellular carcinoma  Motohisa Tada, Osamu Yokosuka, Kenichi Fukai, Tetsuhiro Chiba, Fumio Imazeki, Takeshi Tokuhisa, Hiromitsu Saisho  Journal of Hepatology  Volume 42, Issue 4, Pages 511-519 (April 2005) DOI: 10.1016/j.jhep.2004.11.024 Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 1 RT-PCR analysis of NQO1 expression in hepatoma cell lines. (A) Without treatment with 5-Aza-CdR, NQO1 mRNA expression was down-regulated in Hep3B and HuH6 cells. After treatment with 5-Aza-CdR, NQO1 transcription was restored in Hep3B and HuH6 cells. (B) RNA samples were also amplified using β-actin gene primers as control. +, 5-Aza-CdR-treated; −, untreated. Journal of Hepatology 2005 42, 511-519DOI: (10.1016/j.jhep.2004.11.024) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Methylation status of 24 CpG dinucleotides located between −113 and +219 in the promoter and exon 1 of NQO1 gene. Bisulfite sequencing was performed to determine the methylation status of the 5′CpG island of NQO1 gene in each cell line indicated. Each circle indicates a CpG site in the primary DNA sequence, and each line of circles represents the analysis of a single cloned allele. Closed circles, methylated CpG dinucleotides; open circles, unmethylated CpG dinucleotides. The 5′CpG island of NQO1 was densely methylated in each clone of HuH6 cells and in five of 10 clones of Hep3B cells, while few nucleotides were methylated in HLE, HepG2 and PLC/PRF/5, and no CpG dinucleotide was methylated in HuH7. Journal of Hepatology 2005 42, 511-519DOI: (10.1016/j.jhep.2004.11.024) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 3 MSP analysis performed to assess the methylation status of the 5′CpG island of NQO1 in hepatoma cells. (A) Without treatment with 5-Aza-CdR. (B) Treatment with 5-Aza-CdR. MSP analysis revealed that the 5′CpG island of NQO1 was hypermethylated in Hep3B and HuH6 cells without treatment with 5-Aza-CdR. After treatment with 5-Aza-CdR, the 5′CpG island of NQO1 was demethylated in Hep3B and HuH6 cells. M, methylated; U, unmethylated. Journal of Hepatology 2005 42, 511-519DOI: (10.1016/j.jhep.2004.11.024) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 4 ChIP assay. Crosslinked chromatin from each cell line was incubated with acetylated histones H3 (A) and H4 (B). Immnoprecipitates from each antibody were aliquotted and analyzed by PCR with primer specific NQO1 promoter. Acetylated histone H3 and H4 were undetectable in Hep3B and HuH6 cells without treatment with trichostatin A, while they were abundant in HLE, HuH7, HepG2 and PLC/PRF/5 cells. But histones H3 and H4 were also deacetylated in Hep3B and HuH6 cells after treatment with trichostatin A. +, TSA-treated; −, untreated. Journal of Hepatology 2005 42, 511-519DOI: (10.1016/j.jhep.2004.11.024) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions

Fig. 5 Representative results of MSP analysis of NQO1 and GSTP1 hypermethylation in primary human HCC tumors and corresponding non-tumorous liver tissues. (A) Analysis of NQO1 hypermethylation. (B) Analysis of GSTP1 hypermethylation. Case 1 and Case 3 were hypermethylated at NQO1 gene and Case 1 and Case 2 were hypermethylated at GSTP1 gene. Corresponding non-tumorous liver tissues were neither methylated at NQO1 gene nor GSTP1 gene in the three cases. M, methylation; U, unmethylation. Journal of Hepatology 2005 42, 511-519DOI: (10.1016/j.jhep.2004.11.024) Copyright © 2004 European Association for the Study of the Liver Terms and Conditions